These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Garcia Vidal C; Rodríguez Fernández S; Martínez Lacasa J; Salavert M; Vidal R; Rodríguez Carballeira M; Garau J Clin Infect Dis; 2005 Mar; 40(5):756-9. PubMed ID: 15714425 [TBL] [Abstract][Full Text] [Related]
28. [Specific features of diagnosis and treatment of patients with pulmonary sarcoidosis and tuberculosis]. Kostina ZI; Brazhenko NA; Gerasimova EV; Kol'nikova OV Probl Tuberk; 1998; (2):10-3. PubMed ID: 9613175 [TBL] [Abstract][Full Text] [Related]
29. [Analysis of influencing factors of pneumoconiosis complicated with pulmonary tuberculosis]. Zheng BN; Liu HT; Liang HD; Du YH; Lu JH Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Jul; 39(7):519-522. PubMed ID: 34365763 [No Abstract] [Full Text] [Related]
30. [Improved technology of chemotherapy of pulmonary tuberculosis complicated by other diseases]. Gavril'ev SS; Nikolaev VP; Vinokurova MK; Petukhova NIu; Gavril'eva LP; Malogulova ISh Probl Tuberk; 2001; (2):8-11. PubMed ID: 11490482 [TBL] [Abstract][Full Text] [Related]
31. [Results of surgical intervention depending on duration of preoperative treatment of pulmonary tuberculosis patients]. Grigorian VA; Golovchenko RN; Ustinov AI Probl Tuberk; 2001; (9):20-1. PubMed ID: 11858081 [TBL] [Abstract][Full Text] [Related]
32. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria]. Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553 [TBL] [Abstract][Full Text] [Related]
33. [Predictive value of endopulmonic cytogram in pulmonary tuberculosis among workers having concomitant chronic bronchitis and engaged into industry with pneumoconiosis hazard]. Burukhina LV; Zhdakaev MS; Perminova IV; Tiurin ZhG Med Tr Prom Ekol; 2007; (10):31-6. PubMed ID: 18051847 [TBL] [Abstract][Full Text] [Related]
34. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]
35. [Effectiveness of different chemotherapy regimens in newly detected patients with destructive pulmonary tuberculosis]. Omarov TO; Shefer LB; V'iushkova SV; Abzharkenova ESh Probl Tuberk; 1987; (4):15-7. PubMed ID: 3601919 [No Abstract] [Full Text] [Related]
36. Pattern of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria. Awoyemi OB; Ige OM; Onadeko BO Afr J Med Med Sci; 2002 Mar; 31(1):25-31. PubMed ID: 12518925 [TBL] [Abstract][Full Text] [Related]
37. [Detection of Mycobacterium tuberculosis infection in children with bronchopulmonary diseases and evaluation of its role in the course of disease]. Klochkova LV; Korol' OI Probl Tuberk; 1995; (5):37-9. PubMed ID: 7567891 [TBL] [Abstract][Full Text] [Related]
38. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis]. Zozuliak VI Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824 [No Abstract] [Full Text] [Related]
39. [Diagnosis and treatment of acute progressive tuberculosis types]. Khomenko AG; Mishin VI Probl Tuberk; 1996; (5):21-3. PubMed ID: 8984482 [TBL] [Abstract][Full Text] [Related]